NOMOS Radiation Oncology, a division of North American Scientific, has announced that it received FDA clearance to market nomosSTAT, the serial tomotherapy automated treatment solution, which was introduced at the 47th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in October 2005.
nomosSTAT integrates nomosSTAT MLC and AutoCrane with a single user interface and connects to the CORVUS IMRT inverse planning system.
According to NOMOS, the solution is the only after-market, add-on serial tomotherapy delivery package offered as an upgrade to an existing linear accelerator, and it provides an affordable, turnkey solution for facilities that want IMRT as part of their cancer treatments without the need to have an IMRT-enabled linear accelerator.
November 16, 2021 
